Skip to main content

AI Proves Useful for Ovarian Cancer Diagnosis

By Dennis Thompson HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 5, 2025.

via HealthDay

FRIDAY, Jan. 3, 2025 -- AI can outperform human doctors when it comes to identifying ovarian cancer from ultrasound images.

A new study published in the journal Nature Medicine shows that specially trained AI program achieved an accuracy rate of more than 86% in identifying ovarian cancer by scanning ultrasounds, compared to just under 83% for human experts and nearly 78% for non-expert examiners.

“Ovarian tumors are common and are often detected by chance,” researcher Elisabeth Epstein, a senior physician with the Stockholm South General Hospital’s Department of Clinical Science and Education, said in a news release from the Karolinska Institute in Sweden.

These results suggest that AI “can offer valuable support in the diagnosis of ovarian cancer, especially in difficult-to-diagnose cases and in settings where there’s a shortage of ultrasound experts,” Epstein said.

For the study, researchers trained an AI program to be able to tell the difference between benign and malignant ovarian lesions, using more than 17,000 ultrasound images from nearly 3,700 patients across 20 hospitals in eight countries.

The AI program also cut back on the need for expert referrals, by backing up human doctors, researchers found.

In a simulated care scenario, support from the AI cut the number of referrals by 63% and the misdiagnosis rate by 18%.

Overall, these results show that AI could contribute to faster and more cost-effective care for patients with ovarian lesions, researchers concluded.

However, the research team noted that more studies are needed to validate their findings and fully explore the potential helpfulness of AI.

They are now conducting research to evaluate the everyday clinical safety and usefulness of the program, and are planning for a clinical trial to examine the AI’s effect on patient management and health care costs.

“With continued research and development, AI-based tools can be an integral part of tomorrow’s healthcare, relieving experts and optimizing hospital resources, but we need to make sure that they can be adapted to different clinical environments and patient groups,” co-lead researcher Filip Christiansen, a doctoral student in Epstein’s research group at Karolinska Institute, said in a news release.

Sources

  • Karolinska Institute, news release, Jan. 2, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Read this next

8 Babies Born Using New IVF Technique to Prevent Rare Genetic Diseases

FRIDAY, July 18, 2025 — A new IVF technique helped eight babies in the U.K. avoid serious inherited diseases, and scientists are calling it a breakthrough. All eight...

Hispanic People Have Unexplained Higher Risk For Nerve Disorder

FRIDAY, July 18, 2025 — Hispanic people are more likely to develop peripheral neuropathy than white people, and it’s not clear why, a new study has found. Hispanic...

Living Near Polluted Missouri Creek as a Child Tied to Later Cancer Risk

THURSDAY, July 17, 2025 — Folks who grew up near a polluted Missouri creek during the 1940s through 1960s may have higher odds for cancer now, new research shows. The study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.